Gallbladder Cancer Overview

Save information for later
Sign Up

Learn About Gallbladder Cancer

What is the definition of Gallbladder Cancer?
A benign or malignant neoplasm affecting the gallbladder. Representative examples of benign neoplasms include lipoma, leiomyoma, and neurofibroma. Representative examples of malignant neoplasms include carcinoma, lymphoma, and sarcoma.
What are the alternative names for Gallbladder Cancer?
  • Gallbladder cancer
What are the different types of Gallbladder Cancer?

Common conditions include: Gallbladder Adenocarcinoma

Who are the top Gallbladder Cancer Local Doctors?
Kamran Idrees
Dr. Kamran Idrees
Surgical Oncology | General Surgery
Dr. Kamran Idrees
Surgical Oncology | General Surgery

Vanderbilt University Medical Center

1211 Medical Ctr Dr, 
Nashville, TN 
 (87.5 mi)
615-322-5000
Languages Spoken:
English, Pashto, Urdu
See accepted insurances
Accepting New Patients
Offers Telehealth

Kamran Idrees is a Surgical Oncologist and a General Surgeon in Nashville, Tennessee. Dr. Idrees and is rated as an Elite provider by MediFind in the treatment of Gallbladder Cancer. His top areas of expertise are Gallbladder Cancer, Neuroendocrine Tumor, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Pancreatectomy. Dr. Idrees is currently accepting new patients.

Dr. Deepa R. Magge
Surgical Oncology | General Surgery
Dr. Deepa R. Magge
Surgical Oncology | General Surgery

Vanderbilt University Medical Center

1301 Medical Ctr Dr, 
Nashville, TN 
 (87.6 mi)
615-322-5000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Deepa Magge is a Surgical Oncologist and a General Surgeon in Nashville, Tennessee. Dr. Magge and is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Cancer. Her top areas of expertise are Gallbladder Cancer, Gallbladder Disease, Colorectal Cancer, Pancreatectomy, and Pancreaticoduodenectomy. Dr. Magge is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Laura W. Goff
Hematology Oncology | Oncology | Hematology
Dr. Laura W. Goff
Hematology Oncology | Oncology | Hematology

Vanderbilt Health Clinicians, LLC

3601 The Vanderbilt Clinic, 
Nashville, TN 
 (87.7 mi)
615-322-3000
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Laura Goff is a Hematologist Oncology specialist and an Oncologist in Nashville, Tennessee. Dr. Goff and is rated as a Distinguished provider by MediFind in the treatment of Gallbladder Cancer. Her top areas of expertise are Cholangiocarcinoma (Bile Duct Cancer), Colorectal Cancer, Pancreatic Cancer, Pancreaticoduodenectomy, and Liver Embolization. Dr. Goff is currently accepting new patients.

View All Doctors
What are the latest Gallbladder Cancer Clinical Trials?
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma
Safety and Feasibility of Prophylactic Heated Intra-peritoneal Chemotherapy (HIPEC) for High-Risk Gallbladder Adenocarcinoma
Enrollment Status: Recruiting
Publish Date: February 24, 2025
Intervention Type: Drug
Study Phase: Early Phase 1

Summary: Gallbladder adenocarcinoma is a devastating disease associated with a poor prognosis. Gallbladder and other biliary cancers will be responsible for an estimated 11,980 new cases, and 4,090 deaths in the US during 2020. The 5-year survival for all patients with gallbladder cancer is 18%, however this plummets to 2% for patients with metastatic disease. Patients with gallbladder cancer frequently de...

Match to trials
Find the right clinical trials for you in under a minute
Get started
FOLFOX in Combination With Binimetinib as 2nd Line Therapy for Patients With Advanced Biliary Tract Cancers With MAPK Pathway Alterations: A ComboMATCH Treatment Trial
FOLFOX in Combination With Binimetinib as 2nd Line Therapy for Patients With Advanced Biliary Tract Cancers With MAPK Pathway Alterations: A ComboMATCH Treatment Trial
Enrollment Status: Recruiting
Publish Date: February 21, 2025
Intervention Type: Procedure, Drug
Study Phase: Phase 2

Summary: This phase II ComboMATCH treatment trial compares the usual treatment of modified leucovorin, fluorouracil and oxaliplatin (mFOLFOX6) chemotherapy to using binimetinib plus mFOLFOX6 chemotherapy to shrink tumors in patients with biliary tract cancers that have spread to other places in the body (advanced) and had progression of cancer after previous treatments (2nd line setting). Fluorouracil is i...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center